Patent AT-E401071-T1: [Translated] USES AND COMPOSITIONS FOR SELECTIVE CANCER CHEMOTHERAPY
Description
A selective chemotherapy method includes the step of contacting tumor cells with a mineral ascorbate/vitamin C metabolite composition. A chemotherapeutic composition comprises the mineral ascorbate/vitamin C metabolite composition in a pharmacologically acceptable intravenous carrier.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E401071-T1: [Translated] USES AND COMPOSITIONS FOR SELECTIVE CANCER CHEMOTHERAPY on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401071-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem